Correlation Between Intestinal Microecology Imbalance and Stroke in Young Adults
The relationship between the intestinal microecology and stroke has become a research hotspot in neurology field today. Maintaining the balance of the intestinal microbiota are expected to bring new breakthroughs for prevention and treatment of stroke. In recent years, stroke in young adults has an increasing incidence
| Condition(s) | Ischemic Stroke, Hemorrhagic Stroke |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The relationship between the intestinal microecology and stroke has become a research hotspot in neurology field today. Maintaining the balance of the intestinal microbiota are expected to bring new breakthroughs for prevention and treatment of stroke. In recent years, stroke in young adults has an increasing incidence and a considerable socioeconomic impact because of high disability rate and health-care costs. So there is an urgent need to explore the role and mechanism of intestinal microecology imbalance in stroke, especially in the development and prognosis of stroke in young people. This study aims to use multi-omics technologies, including microbial diversity, metagenomics and metabonomics, to reveal the characteristics of intestinal flora in young stroke patients, identify biomarke |
| Who can participate | Inclusion Criteria: * Clinical diagnosis of acute ischemic or hemorrhagic stroke * Admission within 12 hours * Aged 18-45 years Exclusion Criteria: * History of neurological diseases, myocardial infarction, renal and hepatic abnormalities and metabolic diseases * Combined with tumors, inflammatory bowel disease and other digestive system diseases * Combined with serious life-threatening diseases or condition * Any antibiotics, probiotics or prebiotic treatment within 3 months * Deteriorate and die before collecting faecal samples |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Shanghai 6th People's Hospital |
| Locations | Shanghai, China; Shanghai, China |
| Start date | 2022-02-01 |
| NCT ID | NCT05113043 |
| Official listing | https://clinicaltrials.gov/study/NCT05113043 |